NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球生物技術市場:應用、最終用戶、地區競爭預測和機會 (2026)

Global Biotechnology Market, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 1024094
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球生物技術市場:應用、最終用戶、地區競爭預測和機會 (2026) Global Biotechnology Market, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026
出版日期: 2021年08月01日內容資訊: 英文 111 Pages
簡介

2020 年全球生物技術市場估計為 6276.3 億美元,預計在預測期內以 8.57% 的複合年增長率增長。該市場的增長是由包括食品、農業和醫療保健在內的各種終端用戶行業對生物技術應用和產品不斷增長的需求推動的。生物技術投資的增加和合成生物學需求的增加也可能刺激未來幾年的市場增長。此外,冠狀病毒病(COVID-19)大流行的爆發和蔓延增加了對疫苗、診斷測試和藥品等生物技術產品的需求,這對市場增長產生了積極影響。此外,技術進步以及人工智能和大數據分析等技術的引入和融合,預計將為未來幾年生物技術領域的增長提供有利機會。

本報告探討了全球生物技術市場,提供了市場和產品概述、新型冠狀病毒感染 (COVID-19) 的市場影響、市場份額和應用、最終用戶和地區以及市場份額的預測。它總結了驅動因素的分析因素和問題、市場趨勢、主要公司簡介等。

目錄

第 1 章產品概述

第二章調查方法

第 3 章嚴重急性呼吸系統綜合症 (COVID-19) 對生物技術市場的影響

第 4 章執行摘要

第五章全球生物技術市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按應用(生物製藥、生物 IT、生物工業、生物農業)
    • 按最終用戶(製藥/生物製藥、研究所/實驗室、學術機構等)
    • 按地區
    • 按公司 (2020)
  • 產品市場地圖

第六章北美生物技術市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按應用程序
    • 最終用戶
    • 按國家/地區
  • 國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章歐洲生物技術市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按應用程序
    • 最終用戶
    • 按國家/地區
  • 國家分析
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙

第八章亞太生物技術市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按應用
    • 最終用戶
    • 按國家/地區
  • 國家分析
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞

第 9 章南美生物技術市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按應用程序
    • 最終用戶
    • 按國家/地區
  • 國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東/非洲生物技術市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按應用程序
    • 最終用戶
    • 按國家/地區
  • 國家分析
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 11 章市場動態

  • 促進因素
  • 挑戰

第 12 章市場趨勢

第十三章競爭形勢

  • Novo Nordisk A/S
  • Regeneron Pharmaceuticals Inc.
  • Amgen, Inc.
  • CSL Limited
  • Gilead Sciences, Inc.
  • Celgene Corporation
  • Allergan, Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche AG
  • Seagen Inc.
  • Genmab A/S
  • Biocon Limited
  • Johnson & Johnson
  • Pfizer Inc.

第 14 章戰略建議

第 15 章關於 TechSci Research和免責聲明

目錄
Product Code: 7573

Global biotechnology market stood at USD627.63 billion in 2020 and is expected to grow at a CAGR of 8.57% during the forecast period. The growth can be ascribed to the growing demand for biotechnology applications and products across various end user industries including food, agriculture, healthcare, among others. Additionally, growing investments in the field of biotechnology as well as increasing demand for synthetic biology are further expected to spur the market growth over the next few years. Furthermore, the sudden outbreak and spread of the COVID-19 pandemic has increased the demand for biotechnology products such as vaccines, diagnostic tests, drugs, among others; thereby positively impacting the market growth. Besides, technological advancements and adoption & intersection of technologies such as Artificial Intelligence, Big Data Analytics, among others in the field of biotechnology is further expected to create lucrative opportunities for the growth over the next few years.

The global biotechnology market can be segmented based on application, end user, region and company. Based on application, the market can be categorized into bio-pharmaceuticals, bio-IT, bio-industrial and bio-agriculture. The bio-pharmaceuticals application segment is expected to dominate the market in 2020 with an overall market share of around 34.43%. This can be ascribed to the growing prevalence of different chronic and infectious diseases which require novel drugs for treatment. Furthermore, growing focus on the development of regenerative medicine coupled with increasing pharmaceutical expenditure across globe is further expected to support the segmental growth.

Regionally, North America dominated the market in 2020 and is expected to continue its dominance over the forecast period on account of high healthcare and R&D expenditure. Additionally, growing awareness and adoption pertaining to biotechnology and its applications and use in the region is further expected to boost the market growth. Also, the presence of major market players in the region is expected to further support the market growth. The companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry.

Major companies operating in the global biotechnology market include Novo Nordisk A/S,

Regeneron Pharmaceuticals Inc., Amgen, Inc., CSL Limited, Gilead Sciences, Inc., Celgene Corporation, Allergan, Inc., Biogen Inc., Vertex Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Seagen Inc., Genmab A/S, Biocon Limited, Johnson & Johnson, Pfizer Inc., among others. The companies operating in the market are adopting various strategies like mergers & acquisitions, new product launches, new technology developments and investing in small start-up-companies in order to stay competitive in the market. For instance, in September 2020, F. Hoffmann-La Roche Ltd. completed the acquisition of Inflazome. Inflazome is an Irish biotechnology company which is involved in the development of inflammasome inhibitors. With this acquisition all the products of Inflazome will be added to the product portfolio of Roche. Also, in February 2021, Biogen Inc. received the U.S. FDA approval for PLEGRIDY (peginterferon beta-1a) that is used for the treatment of relapsing forms of multiple sclerosis. This approval will help the company expand its portfolio for multiple sclerosis treatments.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global biotechnology market from 2016 to 2020.
  • To estimate and forecast the market size of the global biotechnology market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global biotechnology market based on application, end user, regional distribution, and company.
  • To identify dominant region or segment in the global biotechnology market.
  • To identify drivers and challenges for global biotechnology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global biotechnology market.
  • To identify and analyze the profile of leading players operating in global biotechnology market.
  • To identify key sustainable strategies adopted by market players in global biotechnology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global biotechnology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Biotechnology companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to biotechnology market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers and partners, End User, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global biotechnology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Biotechnology Market, By Application:

  • Bio-Pharmaceuticals
  • Bio-IT
  • Bio- Industrial
  • Bio-Agriculture

Global Biotechnology Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Research Institutes & Laboratories
  • Academic Institutions
  • Others

Global Biotechnology Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global biotechnology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Biotechnology Market

4. Executive Summary

5. Global Biotechnology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Bio-Pharmaceuticals, Bio-IT, Bio- Industrial, Bio-Agriculture)
    • 5.2.2. By End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2020)
  • 5.3. Product Market Map

6. North America Biotechnology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biotechnology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Biotechnology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Biotechnology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End User

7. Europe Biotechnology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biotechnology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End User
    • 7.3.2. France Biotechnology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Biotechnology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Biotechnology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Biotechnology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End User

8. Asia-Pacific Biotechnology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biotechnology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End User
    • 8.3.2. Japan Biotechnology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End User
    • 8.3.3. India Biotechnology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Biotechnology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Biotechnology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End User

9. South America Biotechnology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biotechnology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Biotechnology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Biotechnology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End User

10. Middle East and Africa Biotechnology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biotechnology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Biotechnology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Biotechnology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End User
    • 10.3.4. Kuwait Biotechnology Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Application
        • 10.3.4.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Novo Nordisk A/S
  • 13.2. Regeneron Pharmaceuticals Inc.
  • 13.3. Amgen, Inc.
  • 13.4. CSL Limited
  • 13.5. Gilead Sciences, Inc.
  • 13.6. Celgene Corporation
  • 13.7. Allergan, Inc.
  • 13.8. Biogen Inc.
  • 13.9. Vertex Pharmaceuticals, Inc.
  • 13.10. F. Hoffmann-La Roche AG
  • 13.11. Seagen Inc.
  • 13.12. Genmab A/S
  • 13.13. Biocon Limited
  • 13.14. Johnson & Johnson
  • 13.15. Pfizer Inc.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Figures

  • Figure 1: Global Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 3: Global Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 4: Global Biotechnology Market Share, By Region, By Value, 2016-2026F
  • Figure 5: Global Biotechnology Market Share, By Company, By Value, 2020
  • Figure 6: North America Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 7: North America Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 8: North America Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 9: North America Biotechnology Market Share, By Country, By Value, 2016-2026F
  • Figure 10: United States Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 11: United States Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 12: United States Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 13: Canada Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 14: Canada Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 15: Canada Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 16: Mexico Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 17: Mexico Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 18: Mexico Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 19: Europe Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 20: Europe Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 21: Europe Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 22: Europe Biotechnology Market Share, By Country, By Value, 2016-2026F
  • Figure 23: Germany Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 24: Germany Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 25: Germany Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 26: France Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 27: France Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 28: France Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 29: United Kingdom Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 30: United Kingdom Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 31: United Kingdom Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 32: Italy Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 33: Italy Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 34: Italy Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 35: Spain Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 36: Spain Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 37: Spain Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 38: Asia Pacific Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 39: Asia Pacific Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 40: Asia Pacific Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 41: Asia Pacific Biotechnology Market Share, By Country, By Value, 2016-2026F
  • Figure 42: China Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 43: China Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 44: China Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 45: Japan Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 46: Japan Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 47: Japan Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 48: India Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: India Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 50: India Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 51: South Korea Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 52: South Korea Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 53: South Korea Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 54: Australia Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 55: Australia Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 56: Australia Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 57: South America Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 58: South America Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 59: South America Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 60: South America Biotechnology Market Share, By Country, By Value, 2016-2026F
  • Figure 61: Brazil Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 62: Brazil Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 63: Brazil Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 64: Argentina Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 65: Argentina Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 66: Argentina Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 67: Colombia Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 68: Colombia Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 69: Colombia Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 70: Middle East & Africa Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 71: Middle East & Africa Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 72: Middle East & Africa Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 73: Middle East & Africa Biotechnology Market Share, By Country, By Value, 2016-2026F
  • Figure 74: South Africa Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 75: South Africa Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 76: South Africa Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 77: Saudi Arabia Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 78: Saudi Arabia Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 79: Saudi Arabia Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 80: UAE Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 81: UAE Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 82: UAE Biotechnology Market Share, By End User, By Value, 2016-2026F
  • Figure 83: Kuwait Biotechnology Market Size, By Value (USD Billion), 2016-2026F
  • Figure 84: Kuwait Biotechnology Market Share, By Application, By Value, 2016-2026F
  • Figure 85: Kuwait Biotechnology Market Share, By End User, By Value, 2016-2026F